Women's Health Care Physicians     |  Find an Ob-Gyn   |  Contact Us   |  About Us   |  ACOG Home   |  
Search public website
Search Help
Login to search entire site
ACOG NEWS RELEASE

For Release: October 24, 2006

Multiple Pregnancy and Birth: Considering Fertility Treatments

Washington, DC -- The American College of Obstetricians and Gynecologists (ACOG), along with the American Society for Reproductive Medicine and the March of Dimes, has issued a consumer document on fertility treatments and their associated risks for multiple pregnancy and premature birth.

"Over the last few decades, assisted reproductive technology (ART) has been associated with a 30-fold increase in multiple pregnancies. It is critical that obstetrician-gynecologists educate our patients who are undergoing fertility treatments on the possible obstetric and perinatal risks, as well as the socioeconomic consequences, of multiple births," said Ralph W. Hale, MD, ACOG executive vice president. "Addressing these issues with couples seeking ART may play a significant role in their decisions regarding the number of embryos to be transferred." ACOG strongly supports the effort toward lowering the risk of multiple births with ART.

This consumer document discusses health concerns and outcomes from fertility therapy, including the risks of multiple pregnancies such as prematurity and low birthweight. It also reviews issues associated with multiple births, including choosing a fertility program, carrying and delivering multiples, and coping with the challenges of parenting multiples.

Please click here to view the consumer document on "Multiple Pregnancy and Birth: Considering Fertility Treatments."

# # #

The American College of Obstetricians and Gynecologists is the national medical organization representing over 51,000 members who provide health care for women.

|  ACOG Member Login  |
Privacy Statement | Important Disclaimer | Copyright Infringement | Terms of Use | Contact Us
Copyright © 2008 American College of Obstetricians and Gynecologists. All rights reserved.